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The factors enhancing mucocoele development in dogs remain poorly understood. A 7-year-old female
spayed Miniature Schnauzer was presented to the Massey University Veterinary Teaching Hospital for
progressive lethargy, inappetance and abdominal discomfort. Initial physical examination findings
revealed a moderate degree of cranial abdominal pain, with subsequent diagnostic tests confirming
the patient as having diabetes mellitus, with a concurrent marked hypertriglyceridaemia. In an attempt
to localise the source of pain, an ultrasound examination of the abdomen was performed, revealing a
marked degree of gallbladder sludge. With appropriate medical management including ursodeoxycholic
acid and insulin therapy, the patient stabilised and was discharged. With persistence of clinical signs
three months later, progression of the gallbladder sludge towards mucocoele development was sus-
pected. Exploratory laparotomy was instigated, and an emergency cholecystectomy was performed.
This case report therefore entails a suspected gallbladder mucocoele that developed in a diabetic patient
with previously diagnosed biliary sludge. A unique feature of this case report is the presence of diabetes
mellitus, which has been suggested to be a causative factor in the development of gallbladder muco-
coeles. It is also hypothesised that gallbladder sludge and mucocoeles are associated, however it is yet
to be ascertained whether this association is causal or contributory. The authors examined the possible
relationship between this endocrinopathy and biliary sludge, and their possible effects on mucocoele
development. Specific associated factors to sludge formation are also examined. The medical and surgical
management of gallbladder mucocoeles is discussed.
 2017 Faculty of Veterinary Medicine, Cairo University. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Biliary sludge has been defined as a mixture of precipitated
crystals, glycoproteins, cellular debris and mucin [1]. Although its
composition varies, cholesterol monohydrate crystals, calcium
bilirubinate and other calcium salts are the main constituents
[2]. Gallbladder sludge has often been considered an incidental
finding by radiologists [3], and can occur secondarily to stagnant
biliary flow and gallbladder dysmotility. During such cases of sta-
sis, water reabsorption thickens the bile, predisposing to obstruc-
tion. The factors enhancing mucocoele development in dogs
remain poorly understood. Some authors have previously attribu-
ted obstruction of the common bile or cystic duct to be an inciting
factor [4,5]. It is the build-up of intraluminal mucous and/or inspis-sated bile within the gallbladder, in conjunction with the presence
of pathognomonic histopathological findings of cystic mucinous
hyperplasia, that characterises it as being a mucocoele [6].
This case report describes a patient with gallbladder sludge sug-
gesting the presence of gallbladder dysmotility and/or a change in
the biliary composition. The exact pathogenesis of gallbladder
mucocoele formation has not been formally identified, and instead
only hypothesised. It is however associated with cystic mucinous
hyperplasia and gallbladder dysmotility suggesting a possible
association with biliary sludge which arises via a similar dysfunc-
tion of gallbladder motility. The association between sludge and
mucocoele formation has been minimally described in the litera-
ture, and this case report outlines initial information into the pos-
sibility that sludge may contribute towards progression to
mucocoele formation, however further studies would be necessary
to clarify this linkage. The specific underlying associated factors of
this case are described, and medical and surgical management is
discussed.
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A 7-year-old female spayed Miniature Schnauzer was presented
to the referring veterinarian following development of polydipsia
and polyuria after a protracted disease course of lethargy noticed
for roughly one month’s duration. As part of an initial database, a
urinalysis was performed and revealed a marked glucosuria, and
consequently, a fasting serum glucose was assessed. This measured
28.2 mmol/L (reference range (RR) 3.9–6.1 mmol/L) and was signif-
icantly elevated. Stress-associated hyperglycaemia was considered,
along with diabetes mellitus, with the latter diagnosis subse-
quently confirmed by examination of serum fructosamine, which
showed marked elevation (690 lmol/L; RR 225–365 lmol/L). A
day after diagnosis, the owners noted significant abdominal dis-
comfort, and the patient was referred to the Massey University
Veterinary Teaching Hospital with concerns of acute pancreatitis
owing to this abdominal discomfort and recent diabetes mellitus
diagnosis. However, no gastrointestinal signs of vomiting or anor-
exia were noted.
Physical examination findings included cranial abdominal pain
characterised by groaning and shaking during palpation. The
patient was of a body condition score of 6/9, and weighed 10 kg.
She appeared considerably lethargic and was correspondingly hos-
pitalised. A complete blood count (CBC), biochemistry profile
including serum triglycerides, and urinalysis were undertaken. Sig-
nificant abnormalities included a moderate increase in serum glu-
cose (26.4 mmol/L; RR 3.9–6.1 mmol/L), a moderate increase in
alkaline phosphatase (688 IU/L; RR 0–185 IU/L) and alanine amino-
transferase (137 IU/L; RR 0–75 IU/L). A marked hypercholestero-
laemia was also detected (28.0 mmol/L; RR 3.0–9.0 mmol/L) inFig. 1. Ultrasonographic study of the gallbladder. A: Transverse view displaying gallblad
wall thickness of 1.3 mm at point A and 4.3 mm at point B. B: Transverse view with
heterogeneous, hyperechoic bile (2). D: Highlighted view of heterogeneous bile.conjunction with a marked hypertriglyceridaemia (40.74 mmol/L;
RR 0.6–1.20 mmol/L). Also of note was a mild hyponatraemia
(132 mmol/L; RR 139–153 mmol/L) and a moderate hypochlo-
raemia (92 mmol/L; RR 105–121 mmol/L). CBC examination
revealed a mild mature neutrophilia (17.4  109/L; RR 6.0–
17.0  109/L) and a mild non-regenerative anaemia (0.34L/L; RR
0.37–0.55L/L). Urinalysis was unremarkable other than the pres-
ence of a marked glucosuria, and the occasional lipid droplet visu-
alised on sediment examination.
A radiographic study of the abdomen was requested, with ven-
trodorsal and lateral views obtained. The liver was moderately
enlarged, having blunted borders with protrusion beyond the
costal arches. The rest of the abdominal viscera were unremark-
able, except for the presence of 5–10 variably sized mineral-
opaque calculi in the urinary bladder. Ultrasound examination of
the abdomen revealed a moderately distended gallbladder
(Fig. 1) with heterogeneous hyperechoic bile settling along the
dependent wall. The wall was irregularly and inconsistently thick-
ened, with randomly located swellings suspected to be mucosal
nodules. Also, a focal area of homogeneous hyperechoic material
adhered to the upper aspect of the lumen was detected. This was
suspected to be mucous. There was no evidence of bile duct
obstruction or occlusion.
The irregularity of the gallbladder wall was attributed to biliary
mucosal hyperplasia, and with the inspissated bile, is suggestive of
biliary sludge formation. Percutaneous ultrasound-assisted chole-
cystocentesis was performed however difficulty was encountered
during aspiration owing to the thickness of the gallbladder con-
tents. The patient was placed in dorsal recumbency and the
abdominal skin along the ventral midline was aseptically prepared.der distension with irregular appearance of the wall. Measurements taken reveal a
suspected adhered, hyperechoic mucous plug (1). C: Sagittal section displaying
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gallbladder using the US transducer to locate and subsequently
guide the needle into the correct location. The patient was rather
lethargic and no sedation or anaesthesia was necessary. The aspi-
rated contents were smeared for cytological examination and sub-
mitted for biliary culture.
Cytological examination of obtained samples revealed an acel-
lular substance, with thick, proteinaceous and mucinous blebs.
Culture of the aspirated samples revealed scant growth of Bacillus
spp., with the presence of this bacterium suggestive of sample con-
tamination due to the presence of minimal growth of this organism
following two-day culture. The absence of any microbial organisms
visualised on cytological examination of Romanowsky stained
specimens also provided support of this likely conclusion. However
it must be noted that healthy dogs also periodically harbour bacte-
ria within the gallbladder, and this is often not clinically significant
[7].
A thyroid panel was also performed due to the presence of the
protracted period of lethargy and concurrent high-body condition
score, as well as markedly elevated serum cholesterol concentra-
tions, which could also be elevated for a number of reasons, includ-
ing primary hyperlipidaemia in Miniature Schnauzers, or a result of
diabetes mellitus. A serum TT4 (total T4) was assessed and was
markedly low (2 nmol/L; RR 20–66 nmol/L) which was initially
suggestive of concurrent hypothyroidism. A TSH assay was subse-
quently performed, and measured 0.03 ng/mL (RR 0.03–0.6 ng/mL),
which was within normal limits. The marked reduction in TT4 was
therefore attributed to euthyroid sick syndrome as a result of the
ongoing disease process. Included in the thyroid panel was a mea-
surement of basal serum cortisol levels, which were noted to be at
the low end of the reference range (24 nmol/L; RR 20–230 nmol/L).
Hyperadrenocorticism was unlikely in this case, owing to the nor-
mal basal cortisol levels; however if poor control of diabetes was
suspected then further investigation of adrenal function was to
be performed. The absence of any abnormalities with regards to
the adrenal glands on abdominal ultrasound also yielded favour
against the presence of hyperadrenocorticism, which should
always be considered in cases of possible mucocoele formation
with previous studies indicating a significant association between
this endocrinopathy and this gallbladder condition [8].
A significant presenting finding was the presence of acute cra-
nial abdominal pain, which is often attributable to acute pancreati-
tis. It is well known that the presence of an inflamed pancreas can
disturb biliary flow through the common bile duct, and therefore
contribute to biliary stasis and possible mucocoele development.
Examination of serum levels of pancreatic enzymes revealed no
elevations of serum lipase (151 IU/L; RR 13–200 IU/L) or amylaseFig. 2. Progression of gallbladder disease on the repeated abdominal ultrasound. A: Tr
mucocoele development three months following initial presentation.(450 IU/L; RR 30–1020 IU/L). Ultrasonographic examination of the
pancreas revealed no areas of hypoechogenicity of the parench-
yma, and the surrounding mesentery was homogenous and lacked
hyperechogenicity, suggesting no evidence of any concurrent pan-
creatitis. As a result, a canine pancreatic-specific lipase (cPL)
assessment was not indicated. The abdominal pain in this case
was therefore suspected to be visceral in nature as a result of the
direct effects of distension of the gallbladder and the stimulation
of peritoneal stretch receptors.
The results of the above investigations allowed the presence of
gallbladder sludge to be identified, suggesting dysmotility and
abnormal gallbladder function. In conjunction with the presence
of mucous in the gallbladder, this was suggestive of early signs
of mucocoele development. The hepatomegaly detected was con-
sistent with endocrine, metabolic and inflammatory causes, all of
which were suspected to be occurring simultaneously. Due to the
recent diabetes mellitus diagnosis and marked hypertriglyceri-
daemia, initial therapy was aimed at these endocrine and meta-
bolic concerns. The patient was placed on a low fat diet (Gastro/
Low-fat; Royal Canin, Missouri, USA) in an attempt to alleviate
the hypertriglyceridaemia, as well as allowing appropriate titration
of the newly prescribed insulin therapy (Caninsulin; MSD Animal
Health, Upper Hutt, NZ). An initial dose of 5 IU was prescribed, to
be administered subcutaneously twenty minutes following a meal,
BID (twice-daily). Serial blood glucose measurements were per-
formed, with serum glucose reading 28.5 mmol/L at four hours,
and 22.6 mmol/L at six hours (RR 3.9–6.1 mmol/L) post administra-
tion. Medical management of the biliary sludge was instigated
through the use of the choleretic agent ursodeoxycholic acid (Urso-
san; ABM Pharma Ltd, Auckland, NZ). An initial dose of 125 mg PO
SID (once-daily) was prescribed. The patient was monitored clo-
sely, during which time significant improvement occurred, and
was discharged three days following admission. Monthly check-
ups were advised, to monitor progression of current therapy, and
allow for repeat abdominal ultrasonography.
Three months following initial discharge, the patient suffered
vomiting episodes, with tremors and lethargy necessitating an
emergency revisit. Once more, cranial abdominal pain was
detected during palpation, with moderate dehydration (5%) was
also noted. Repeat haematological examination was requested,
with a CBC and serum biochemistry performed. The previous
abnormalities detected continued to be present, with a significant
increase in the levels of serum alkaline phosphatase (1604 IU/L)
and alanine aminotransferase (466 IU/L). This suggested the pro-
gression of severe cholestasis. The patient’s serum triglyceride
levels had reduced over the prior course of medical therapy, but
were still moderately elevated at 14.27 mmol/L (RR 0.6–ansverse view one month following the first scan. B: Further progression towards
Fig. 3. Intraoperative view of the gallbladder during exploratory laparotomy, prior
to cholecystectomy.
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biliary sludge towards gallbladder mucocoele formation (Fig. 2).
With the absence of any other significant findings, the abdominal
pain was attributed to the gallbladder disease, and an exploratory
laparotomy was requested.
Stabilisation was achieved through correcting dehydration after
placing a 20 g catheter into the right cephalic vein, with compound
sodium lactate administered intravenously. The patient was
premedicated with methadone (0.5 mg/kg IV), before induction
achieved with alfaxalone (2 mg/kg IV). Cefazolin (22 mg/kg IV)
was used as an intra-operative antibiotic, with isoflurane main-
taining anaesthesia as administered via a rebreathing-circle circuit.
Exploratory laparotomy revealed a markedly distended gall-
bladder (Fig. 3) and a cholecystectomy was performed. An initial
incision through the visceral peritoneum using Metzenbaum scis-
sors was made. Traction was applied to the gallbladder as blunt
dissection was undertaken to free it from surrounding hepatic par-
enchyma. The cystic duct and artery were identified, and were
clamped and double-ligated using circumferential ligatures of 3/0
non-absorbable suture (Ethilon; Ethicon, New Jersey, USA), before
being incised distally to allow for gallbladder removal. The excised
tissue was submitted for histological examination, along with duo-
denal and hepatic biopsies.
Postoperatively, the patient was maintained on a remifentanil
constant rate infusion, before being transitioned to methadone
for the provision of analgesia. As pain scores reduced, opioid anal-
gesia was withdrawn in favour of the provision of meloxicam, a
non-steroidal anti-inflammatory drug (Metacam; Boehringer
Ingelheim, Ingelheim, Germany). Antibiotic therapy was also insti-
gated, with clavulanic acid/amoxicillin given PO at a dose rate of
12.5 mg/kg BID (Clavulox; Zoetis, Auckland, NZ). Previous therapy
of ursodeoxycholic acid and insulin was continued, with a marked
clinical improvement seen following surgery. The patient was dis-
charged three days later.
Following discharge, the patient was reported to be doing well.
Previous abdominal discomfort had resolved, and diabetes was
controlled clinically at higher doses of insulin (8IU BID), with the
absence of polyuria, polydipsia and polyphagia. Repeated hepatic
enzyme assays were requested in the following weeks, to assess
for necessity to continue ursodeoxycholic acid therapy.
Histological examination of duodenal biopsies revealed no
significant abnormalities. Examination of the hepatic parench-
yma revealed diffuse, severe biliary hyperplasia, with infiltration
by small to moderate numbers of neutrophils, lymphocytes and
plasma cells. The gallbladder propria submucosa containedmultifocal collections of lymphocytes, with occasional plasma
cells. These findings reflected chronic extra-hepatic functional
cholestasis, likely as a result of elevated pressure in the cystic
and common bile ducts due to sludge and mucous present
within the gallbladder. Pathognomonic histological findings
include cystic mucinous hyperplasia, but this was absent in this
case. Instead, gross and ultrasonographic findings were sugges-
tive of mucocoele formation however they were not a classical
presentation due to the absence of mucosal hyperplasia. In con-
clusion, this differential remained the most likely cause of the
presenting complaint in this case due to the absence of any other
significant abnormalities.3. Discussion
A unique feature of this case is the presence of concurrent
diabetes mellitus with gallbladder mucocoele development. Dia-
betes mellitus is an endocrinopathy that has been previously
suggested to be a cause of gallbladder mucocoeles in dogs
[8,9]. In the retrospective case-control study by Mesich et al.
[8], no significant association was noted between the presence
of concurrent diabetes mellitus and gallbladder mucocoeles. In
this case report, however, the presence of diabetes mellitus is
thought to be a rather significant finding, and it is hypothesised
that this endocrinopathy may directly induce gallbladder muco-
coele development, or has an indirect effect through inducing
hyperlipidaemia and gallbladder dysmotility. In order to ascer-
tain the possibility of diabetes mellitus predisposing to muco-
coele formation, further investigation is warranted to ascertain
whether the metabolic and functional effects on the gallbladder
and biliary composition induced by this endocrinopathy are sig-
nificant enough to result in mucocoele development. This case
report therefore provides an initial indication to suggest that
these two conditions may in fact be associated.
The factors that promote gallbladder mucocoele formation in
dogs are poorly understood [10]. Of the suggested causes, it is
thought that obstruction of the common bile duct, as well as gall-
bladder hypomotility, contribute to the condition. Mucocoele
development may also result from an abnormality of the mucosa
characterised by hyperplasia of mucin-secreting cells that predis-
poses to excessive mucous production [10]. It has not been ascer-
tained whether this is a primary or secondary lesion, however the
reported incidence of this histopathological change following diag-
nosis is roughly 80% [11]. In vitro studies have suggested that expo-
sure to hydrophobic bile acids results in an increase in mucin
production [6]. This combination of factors slows bile progression
through the gallbladder, leading to inspissation, mucosal irritation
and subsequent mucocoele development.
Biliary salts are well described cytotoxic agents [12], and
chronic exposure is hypothesised to result in injury to the epithe-
lial lining of the gallbladder. Cystic mucinous hyperplasia is a uni-
versal sequela of epithelial injury, and the absence of this
histological change in this case may be due to an insufficient time
frame for this to have occurred.
The aetiopathogenesis of biliary sludge formation has been
widely reported in human literature. It is suspected that gallblad-
der dysmotility and hypomotility are the main predisposing factors
[13]. The lack of normal biliary flow through the gallbladder is
reported to result in sedimentation of microcholecystoliths, crys-
tals, mucin and cellular debris. Once formed, biliary sludge is diffi-
cult to clear, with reabsorption of water further inspissating the
material [1]. If allowed to progress, obstruction of the cystic duct
results, through preventing the normal movement of bile, in muco-
coele formation. This mechanism is the suspected pathogenesis in
this case.
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contributing to gallbladder disease in this patient. Primary
breed-specific hyperlipidaemia has been reported in Miniature
Schnauzers [14] and the marked hypertriglyceridaemia and hyper-
cholesterolaemia noted are supportive of this condition. Also the
presence of diabetes mellitus, could equally be contributing to
these findings due to cellular inability to metabolise and utilise
glucose. These biochemical states have a number of effects on
the consistency of bile, namely through increasing the levels of bil-
iary cholesterol leading to the formation of a more viscous material
[15]. The corresponding biliary stasis leads to mucosal irritation
and subsequent increased mucin secretion. This exacerbates the
increasing biliary viscosity, and predisposes to mucocoele
formation.
Cholecystokinin (CCK) is the primary hormone involved in
promoting gallbladder contraction and bile secretion. It is
released by enterocytes when fat from a meal enters the duode-
num [10]. It is proposed that long-standing exposure of entero-
cytes to a hyperlipaemic state reduces CCK release. This
induces gallbladder hypomotility, and could be a contributing
factor to mucocoele development. Insulin resistance has also
shown to have an effect on CCK secretion in humans [16], with
reduced CCK release seen postprandially. Dogs are generally
affected by type I (insulin-dependent) diabetes mellitus charac-
terised by a reduction in the synthesis and secretion of insulin
by b cells in the pancreas. Insulin resistance is therefore uncom-
mon in dogs, and it is not yet known if the reduced insulin
secretion seen in diabetic dogs has any effects on CCK release
in this species. Therefore, the presence of diabetes mellitus in
this case could result in lowered CCK release, reducing gallblad-
der contraction and inducing hypomotility. This predisposes to
mucocoele formation, however without specific studies of CCK
release in dogs in response to reduced levels of insulin; it is dif-
ficult to ascertain whether this CCK secretion pattern seen in
humans also pertains to this case.
Medical therapy instigated was the use of the choleretic agent
ursodeoxycholic acid. This synthetic bile acid functions to displace
hydrophobic bile acids from the circulating pool [6]. The hydrophi-
lic activity draws water into the bile, increasing its fluidity, and
normalising biliary secretion. It also conveys hepatoprotectant
effects through its anti-oxidative properties [17], which not only
aids in relieving the gallbladder congestion, but also protects the
hepatic parenchyma. However this medical therapy does have con-
traindications, particularly for this case. The evidence of biliary
hyperplasia suggests extra-hepatic functional cholestasis was pre-
sent, and this has implications for the use of this drug. Through its
choleretic effects, the volume of the bile is increased and in turn,
places greater pressure on a compromised gallbladder wall,
increasing the risk of gallbladder rupture and subsequent bile peri-
tonitis [3].
Despite these contraindications, the use of ursodeoxycholic acid
was warranted as an initial therapy in this case as there was no evi-
dence of complete biliary obstruction on ultrasound and so the risk
of gallbladder rupture was concluded to be low. In addition,
ursodeoxycholic acid has been shown to reduce bile acid produc-
tion by limiting gastrointestinal absorption of cholesterol [6], fur-
ther providing a choleretic effect and reducing serum cholesterol
concentrations with appropriate management of the concurrent
endocrine disease present. The choleretic, anti-oxidative and
secretion-normalising effects of this drug were considered to out-
weigh its possible complications, particularly for initial manage-
ment as its biliary thinning effects theoretically allow sludgy bile
to exit the gallbladder [10]. It is still unknown whether medical
management will allow resolution of the ultrasonographic changes
seen in the gallbladder in cases of biliary sludge and mucocoele
formation, however with close monitoring including repeating bio-chemical parameters and follow-up ultrasound examination every
6 weeks, this medical therapy can be used to provide time for the
owners to consider cholecystectomy.
Surgical excision of the gallbladder was ultimately necessary to
confer a complete cure. Dogs with gallbladder mucoceles that
undergo cholecystectomy and survive the immediate post-
operative period have an excellent long-term prognosis [18].
Intra-operative complications are severe, with bile leakage
reported in 7% of cases. Bile peritonitis is a common sequel to this,
with a peri-operative mortality rate of 22–40% described [9].
Therefore, cholecystectomy is not performed without risks; how-
ever the mind-set towards this condition has to change. The cur-
rent trend is to delay removal until medical therapy failure as in
this case. However, further emphasis should be placed on removal
of the gallbladder at initial presentation. Cholecystectomy at this
stage would be performed on a gallbladder with a greater degree
of integrity, with minimal compromise of the wall. Correspond-
ingly, an excellent outcome and rapid return to function has been
described [9].
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